Compugen Future Growth
Future criteria checks 1/6
Compugen's earnings are forecast to decline at 22.2% per annum while its annual revenue is expected to grow at 10.8% per year. EPS is expected to decline by 2% per annum.
Key information
-22.2%
Earnings growth rate
-2.0%
EPS growth rate
| Biotechs earnings growth | 45.5% |
| Revenue growth rate | 10.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 39 | -15 | 15 | -28 | 2 |
| 12/31/2025 | 43 | -2 | 2 | -14 | 2 |
| 12/31/2024 | 43 | -2 | 66 | 43 | 2 |
| 6/30/2024 | 43 | -10 | 22 | 22 | N/A |
| 3/31/2024 | 36 | -17 | N/A | N/A | N/A |
| 12/31/2023 | 33 | -19 | -36 | -36 | N/A |
| 9/30/2023 | 8 | -32 | N/A | N/A | N/A |
| 6/30/2023 | 8 | -33 | -32 | -32 | N/A |
| 3/31/2023 | 8 | -33 | N/A | N/A | N/A |
| 12/31/2022 | 8 | -34 | -35 | -34 | N/A |
| 9/30/2022 | N/A | -39 | N/A | N/A | N/A |
| 6/30/2022 | 6 | -34 | -30 | -30 | N/A |
| 3/31/2022 | 6 | -34 | N/A | N/A | N/A |
| 12/31/2021 | 6 | -34 | -23 | -23 | N/A |
| 9/30/2021 | 8 | -34 | N/A | N/A | N/A |
| 6/30/2021 | 2 | -36 | -31 | -30 | N/A |
| 3/31/2021 | 2 | -32 | N/A | N/A | N/A |
| 12/31/2020 | 2 | -30 | -28 | -28 | N/A |
| 9/30/2020 | N/A | -28 | N/A | N/A | N/A |
| 6/30/2020 | N/A | -26 | -23 | -23 | N/A |
| 3/31/2020 | N/A | -26 | N/A | N/A | N/A |
| 12/31/2019 | N/A | -27 | -28 | -28 | N/A |
| 9/30/2019 | N/A | -30 | N/A | N/A | N/A |
| 6/30/2019 | 8 | -27 | -22 | -22 | N/A |
| 3/31/2019 | 8 | -31 | N/A | N/A | N/A |
| 12/31/2018 | 18 | -23 | -13 | -13 | N/A |
| 9/30/2018 | 18 | -23 | N/A | N/A | N/A |
| 6/30/2018 | 10 | -29 | -24 | -23 | N/A |
| 3/31/2018 | 10 | -28 | N/A | N/A | N/A |
| 12/31/2017 | N/A | -37 | N/A | -31 | N/A |
| 9/30/2017 | 0 | -36 | N/A | N/A | N/A |
| 6/30/2017 | 0 | -34 | N/A | -27 | N/A |
| 3/31/2017 | 1 | -32 | N/A | N/A | N/A |
| 12/31/2016 | 1 | -32 | N/A | -20 | N/A |
| 9/30/2016 | 9 | -23 | N/A | N/A | N/A |
| 6/30/2016 | 9 | -22 | N/A | -20 | N/A |
| 3/31/2016 | 9 | -23 | N/A | N/A | N/A |
| 12/31/2015 | 9 | -20 | N/A | -26 | N/A |
| 9/30/2015 | 8 | -21 | N/A | N/A | N/A |
| 6/30/2015 | 9 | -20 | N/A | -17 | N/A |
| 3/31/2015 | 11 | -15 | N/A | N/A | N/A |
| 12/31/2014 | 12 | -11 | N/A | -11 | N/A |
| 9/30/2014 | 8 | -13 | N/A | N/A | N/A |
| 6/30/2014 | 7 | -12 | N/A | -7 | N/A |
| 3/31/2014 | 6 | -13 | N/A | N/A | N/A |
| 12/31/2013 | 4 | -14 | N/A | -6 | N/A |
| 9/30/2013 | 2 | -17 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CGEN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CGEN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CGEN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CGEN's revenue (10.8% per year) is forecast to grow faster than the IL market (2.8% per year).
High Growth Revenue: CGEN's revenue (10.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CGEN's Return on Equity is forecast to be high in 3 years time